miR‑302d‑3p regulates the viability, migration and apoptosis of breast cancer cells through regulating the TMBIM6‑mediated ERK signaling pathway.

Mol Med Rep · 2021 · PMC8548939 · PMID 34651659

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The wound healing assay revealed that, compared with the si-TMBIM6 group, cell migration exhibited a decreasing trend in the miR-302d-3p mimics + si-TMBIM6 group, whereas cell migration increased in the miR-302d-3p inhibitor + si-TMBIM6 group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.